ChemoCentryx, Inc.
DEUTERATED COMPOUNDS AS IMMUNOMODULATORS

Last updated:

Abstract:

Compounds are provided to modulate the C5a receptor. The compounds have the following Formula (I): ##STR00001## including stereoisomers and pharmaceutically acceptable salts thereof, wherein R.sup.1, R.sup.2 and R.sup.3 are as defined herein. Methods associated with preparation and use of such compounds, as well as pharmaceutical compositions comprising such compounds, are also disclosed.

Status:
Application
Type:

Utility

Filling date:

9 Oct 2020

Issue date:

9 Sep 2021